16 February 2024
16 February 2024
The acquisition introduces AIO-001, a long-acting anti-thymic stromal lymphopoietin monoclonal antibody, into GSK's pipeline.
The agency has granted Augtryo priority review status following positive data from two Phase I/II clinical trials that show promising response rates.
Diamyd’s antigen-specific immunotherapy is being evaluated as a treatment for HLA DR3-DQ2 genotype type 1 diabetes (T1D).
The success of recent trials treating mental health problems with psychedelic therapies has driven a rapid rise in investment.
This rare genetic disease is characterised by extremely high triglyceride levels and can lead to recurrent acute pancreatitis.
The FDA released guidance describing the eligibility criteria for companies to recover costs in lieu of access to investigational drugs in clinical studies.
The beleaguered women’s health company has raised €12.8m ($13.7m) from the sale to shore up its uncertain cash position.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
